Annual Report

Overview

The report records Nippon Shinyaku Group's FY2013 net sales of ¥76,517 million, a record, with growth in both pharmaceuticals and functional food. It highlights the April 2014 launch of Zalutia and progress in its drug development pipeline. Environmental disclosures report lower CO2 emissions at main business locations and a 0.4% final landfill waste ratio, alongside CSR activities for patients, employees, and local communities.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2013-2014
Period: 1 April 2013 – 31 March 2014
Language: English
Pages
File size
Restatement: Disclosed

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services